MORGAN ASH: Open Payments
NPI 1639824162 · SCHENECTADY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 24 payments from 11 companies in 2025. Trend: 2023 $192 · 2024 $471 · 2025 $600
Food & beverage: $591Education: $9
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 7 | $162 |
| Medtronic, Inc. | 2 | $145 |
| Alnylam Pharmaceuticals Inc. | 3 | $57 |
| Actelion Pharmaceuticals US, Inc. | 2 | $54 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 3 | $46 |
| E.R. Squibb & Sons, L.L.C. | 2 | $38 |
| SCPHARMACEUTICALS INC. | 1 | $24 |
| Novartis Pharmaceuticals Corporation | 1 | $23 |
| BridgeBio Pharma, Inc. | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
Products named: REPATHA, MICRA, ONPATTRO, UPTRAVI, LifeVest, CAMZYOS, FUROSCIX, LEQVIO.
Industry payments across NY — which companies pay providers there.
